Alphatec (ATEC) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
13 May, 2026Market opportunity and growth strategy
Spine surgery market estimated at $10 billion, with current penetration under 10%.
Lateral surgery market sized at $1 billion, identified as a fast-growing segment due to clinical benefits.
Focus on clinical distinction and procedural adoption to drive surgeon engagement and market share.
Consistent 20% quarterly growth in surgeon adoption since 2024.
Platform approach encourages expansion into broader pathologies and portfolio adoption.
Innovation and technology integration
Investment in patient positioners and neuromonitoring enhances lateral surgery safety and reproducibility.
EOS imaging system and AI-driven EOS Insight software enable automated alignment and longitudinal patient tracking.
Sites using EOS Insight saw 30% volume growth within six months of implementation.
Launch of Valence navigation and surgical robot platform integrated into PTP for predictable lateral surgery.
Robotic and navigation tools broaden accessibility for surgeons with varying lateral experience.
International expansion and financial performance
Strategy focuses on deep penetration in select countries, with recent entries into Australia, New Zealand, and Japan.
First PTP procedure performed in Japan in March, supporting direct sales and higher profitability.
Profitability improved from negative to positive adjusted EBITDA in 2024, with positive cash flow projected through 2026.
Refinanced $200 million in term debt, saving $6 million annually in interest.
2026 guidance targets 15% revenue growth to $882 million, $134 million EBITDA, and $20 million free cash flow.
Latest events from Alphatec
- Q1 2026 revenue up 14% to $192M, with EBITDA doubling and debt costs set to drop $6M+.ATEC
Q1 202611 May 2026 - Shareholders to vote on board elections, auditor ratification, and key compensation plans.ATEC
Proxy filing29 Apr 2026 - Shareholders will vote on directors, auditor, equity plans, and executive pay, with board support.ATEC
Proxy filing29 Apr 2026 - 2025 revenue up 25% to $764M; 2026 guidance raised to $890M and $134M adjusted EBITDA.ATEC
Q4 20259 Apr 2026 - Surgeon adoption, enabling tech, and disciplined capital deployment drive robust growth and share gains.ATEC
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Q3 2024 revenue up 27%, adjusted EBITDA positive, and liquidity boosted by $50M term loan.ATEC
Q3 202413 Feb 2026 - Q2 revenue up 25% to $146M, margin expansion, positive EBITDA, and guidance raised.ATEC
Q2 202413 Feb 2026 - Rapid growth driven by procedural innovation, margin leverage, and targeted expansion.ATEC
Jefferies Global Healthcare Conference1 Feb 2026 - Spine-focused innovation and informatics drive strong growth, profitability, and global expansion.ATEC
44th Annual J.P. Morgan Healthcare Conference30 Jan 2026